Project Grant HT94252410296
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$603K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Belgium
Similar Awards
The Department of the Army Medical Command awarded a $1,035,468 project grant to the Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology (VIB) under the Military Medical Research and Development program (CFDA 12.420). The four-year award beginning September 1, 2021 will support the development of innovative proteomics approaches to identify fluid biomarkers for frontotemporal degeneration. Through this funding, VIB will conduct research to investigate medical solutions...
The Department of the Army Medical Command awarded a $1,045,068 project grant under the Military Medical Research and Development program to the Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology. The grant will fund an innovative proteomics approach to identify fluid biomarkers for frontotemporal degeneration from September 1, 2021 to August 31, 2025. Through this funding, the Vlaams Instituut Voor Biotechnologie will apply proteomics techniques to analyze bodily fluids...
The U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) awarded a $199,908 Project Grant to the Institut National De La Sante Et De La Recherche Medicale (Inserm) to model hemangioblastomas using induced pluripotent stem cells carrying mutations in the von Hippel-Lindau gene. This 2-year project, scheduled for completion by April 30, 2026, aims to transform healthcare for Service Members and the American public through innovative biomedical research. As a...
The federal Project Grant award of $663,190 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to Vrije Universiteit Brussel (V.u.b.) in Belgium supports the "TANDEM 2: CLOSING THE GAP TO INTERVENTIONS FOR TAND" research project. This 3-year project aims to develop new interventions for Tourette Syndrome and associated neuropsychiatric disorders. V.u.b., a private university and non-profit organization, has a proven track record of engaging...
The Van Andel Research Institute was awarded a $950,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 30, 2023 to September 29, 2025 to establish the neuroprotective potential of C9ORF72 hypermethylation in repeat expansion-caused ALS. Through this award, the grantee will investigate medical solutions for the battlefield by transforming health care for service members and the...
This Project Grant from the Defense Health Agency provides $734,781 to Formation Venture Engineering Foundry Inc. for precision medicine immunotherapy research under the Military Medical Research and Development program (CFDA 12.420). The research aims to develop medical solutions for treating neurodegeneration in amyotrophic lateral sclerosis patients who test positive for human endogenous retrovirus K. The awardee will conduct applied and advanced biomedical research from June 2023 through...
This $854,060 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) was provided to Formation Venture Engineering Foundry Inc., a for-profit biotech firm, to develop an FC-fusion protein active vaccine for the prevention and treatment of C9ORF72 ALS/FTD, a rare neurodegenerative disease. The award period is from Apr 15, 2024 to Apr 14, 2026. The Military Medical Research and Development program supports innovative biomedical research...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This $489,065 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of North Carolina at Chapel Hill to investigate "Potentiated Chip Variants as Therapeutics to Alleviate Tau Pathology and Neurodegeneration." The research aims to develop innovative therapeutic approaches to address neurodegenerative conditions relevant to military service members and the broader public....